disability

I’m embarrassed that I was embarrassed. I was walking out of the conference hall with some new acquaintances, making polite small talk about how my firm could support their work — the things you say when you’re trying to make a good impression — and we said our goodbyes and…

People with neuromyelitis optica spectrum disorder (NMOSD) have abnormally high levels of S100A9, a protein that drives the inflammatory activity of certain immune cells, a study discovered. According to the researchers, higher S100A9 levels in the blood were significantly associated with more severe disability among patients. These findings thus…

Most people with neuromyelitis optica spectrum disorder (NMOSD) have impaired sleep quality and architecture — an individual’s cyclical sleep pattern, involving different stages — relative to healthy people, according to a new study from researchers in India. NMOSD patients were also found to have reductions in the volume of…

Smoking is associated with a significantly higher risk of residual disability from onset attack in neuromyelitis optica spectrum disorder (NMOSD) patients with antibodies against the AQP4 protein, a new study showed. Similar results were seen for the presence of nonsmoking vascular risk factors (VRF) such as high blood pressure,…

The platelet-to-lymphocyte ratio, a blood inflammatory marker that can be calculated based on the results of a simple blood test, may be used as a biomarker of disability severity in people with neuromyelitis optica spectrum disorder (NMOSD), a small study showed. Researchers identified four other ratios, calculated based on…

Regular maintenance treatment with low-dose rituximab is associated with less disability and fewer relapses among people with neuromyelitis optica spectrum disorder (NMOSD) compared with receiving irregular doses of the preventive therapy, according to a two-year real-world study in China. “Regular [rituximab] treatment can significantly reduce the annual relapse rate, incidence…

People with neuromyelitis optica spectrum disorder (NMOSD) have significantly higher levels of the signaling molecule CXCL13 in their blood and cerebrospinal fluid (CSF), the liquid surrounding the brain and spinal cord, a study shows. Also, CXCL13 levels were significantly associated with disability, with higher levels being detected in NMOSD…

As a private person, I find it easier to have an invisible disability, despite the emotional toll of appearing “fine” while feeling far from it. For years, I was able to privately manage my symptoms, and I wasn’t constantly asked if I needed help, which allowed me my independence.

People with neuromyelitis optica spectrum disorder (NMOSD) who test positive for NMOSD-driving self-reactive antibodies against the AQP4 protein and Black patients are significantly more likely to have worse disability related to vision. These are the findings of a North American study that analyzed patient data with NMOSD-specific disability scales…

About half of neuromyelitis optica spectrum disorder (NMOSD) patients who test positive for self-reactive antibodies, or autoantibodies, against the AQP4 protein — a hallmark of the autoimmune disease — have at least one other type of autoantibody, according to a new study from South Korea. Many of these other…